Immunosenescence and pneumococcal disease: An imbalance in host-pathogen interactions

The Lancet Respiratory Medicine

Volumn 2, Issue 2, 2014, Pages 141-153

  Krone, Cassandra L ^a   van de Groep, Kirsten ^a   Trzciński, Krzysztof ^a   Sanders, Elizabeth A M ^a   Bogaert, Debby ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGE FACTORS; AGED; AGING; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOCOMPETENCE; INCIDENCE; NETHERLANDS; PNEUMONIA, PNEUMOCOCCAL; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE; WORLD HEALTH;

EID: 84895073832     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(13)70165-6     Document Type: Review

References (132)

1. Mizgerd JP Lung infection-a public health priority. PLoS Med 2006, 3:e76.
2. The global burden of disease: 2004 update 2008, WHO, World Health Organization, Geneva.
3. Loeb M, McGeer A, McArthur M, Walter S, Simor AE Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 1999, 159:2058-2064.
4. Chong CP, Street PR Pneumonia in the elderly: a review of the epidemiology, pathogenesis, microbiology, and clinical features. South Med J 2008, 101:1141-1145.
5. Janssens J-P, Krause K-H Pneumonia in the very old. Lancet Infect Dis 2004, 4:112-124.
6. Fein AM Pneumonia in the elderly: overview of diagnostic and therapeutic approaches. Clin Infect Dis 1999, 28:726-729.
7. van der Sluijs KF, van der Poll T, Lutter R, Juffermans NP, Schultz MJ Bench-to-bedside review: bacterial pneumonia with influenza-pathogenesis and clinical implications. Crit Care 2010, 14:219.
8. Wroe PC, Finkelstein JA, Ray GT, et al. Aging population and future burden of pneumococcal pneumonia in the United States. J Infect Dis 2012, 205:1589-1592.
9. Bogaert D, de Groot R, Hermans PWM Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004, 4:144-154.
10. Bosch AA, Biesbroek G, Trzcinski K, Sanders EA, Bogaert D Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog 2013, 9:e1003057.
11. Weinberger DM, Malley R, Lipsitch M Serotype replacement in disease after pneumococcal vaccination. Lancet 2011, 378:1962-1973.
12. Hill PC, Townend J, Antonio M, et al. Transmission of Streptococcus pneumoniae in rural Gambian villages: a longitudinal study. Clin Infect Dis 2010, 50:1468-1476.
13. O'Brien KL, Nohynek H Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J 2003, 22:e1-11.
14. Regev-Yochay G, Raz M, Dagan R, et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis 2004, 38:632-639.
15. Abdullahi O, Karani A, Tigoi CC, et al. Rates of acquisition and clearance of pneumococcal serotypes in the nasopharynges of children in Kilifi district, Kenya. J Infect Dis 2012, 206:1020-1029.
16. Flamaing J, Peetermans WE, Vandeven J, Verhaegen J Pneumococcal colonization in older persons in a nonoutbreak setting. J Am Geriatr Soc 2010, 58:396-398.
17. Palmu AA, Kaijalainen T, Saukkoriipi A, Leinonen M, Kilpi TM Nasopharyngeal carriage of Streptococcus pneumoniae and pneumococcal urine antigen test in healthy elderly subjects. Scand J Infect Dis 2012, 44:433-438.
18. Ridda I, Macintyre CR, Lindley R, et al. Lack of pneumococcal carriage in the hospitalised elderly. Vaccine 2010, 28:3902-3904.
19. Trzcinski K, Bogaert D, Wyllie A, et al. Superiority of trans-oral over trans-nasal sampling in detecting Streptococcus pneumoniae colonization in adults. PLoS One 2013, 8:e60520.
20. Ansaldi F, De Florentiis D, Parodi V, et al. Bacterial carriage and respiratory tract infections in subjects > or = 60 years during an influenza season: implications for the epidemiology of community acquired pneumonia and influenza vaccine effectiveness. J Prev Med Hyg 2012, 53:94-97.
21. Ansaldi F, de Florentiis D, Canepa P, et al. Carriage of Streptoccoccus pneumoniae in healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children: rationale and perspectives for PCV13 implementation. Hum Vaccin Immunother 2013, 9:614-620.
22. Suzuki N, Yuyama M, Maeda S, Ogawa H, Mashiko K, Kiyoura Y Genotypic identification of presumptive Streptococcus pneumoniae by PCR using four genes highly specific for S pneumoniae. J Med Microbiol 2006, 55:709-714.
23. White B The biology of pneumococcus 1938, The Commonwealth Fund, New York, NY.
24. Heffron R Pneumonia with special reference to pneumococcus lobar pneumonia 1979, Harvard Univeristy Press, Cambridge, MA.
25. Bogaert D, Keijser B, Huse S, et al. Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis. PLoS One 2011, 6:e17035.
26. Biesbroek G, Sanders EA, Roeselers G, et al. Deep sequencing analyses of low density microbial communities: working at the boundary of accurate microbiota detection. PLoS One 2012, 7:e32942.
27. Lemon KP, Klepac-Ceraj V, Schiffer HK, Brodie EL, Lynch SV, Kolter R Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. mBio 2010, 1:e00129. 10.
28. Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 2011, 184:957-963.
29. Preza D, Olsen I, Willumsen T, Grinde B, Paster BJ Diversity and site-specificity of the oral microflora in the elderly. Eur J Clin Microbiol Infect Dis 2009, 28:1033-1040.
30. Incalzi RA, Maini CL, Fuso L, Giordano A, Carbonin PU, Galli G Effects of aging on mucociliary clearance. Compr Gerontol Clin Lab Sci 1989, 3(suppl):65-68.
31. Diamond G, Legarda D, Ryan LK The innate immune response of the respiratory epithelium. Immunol Rev 2000, 173:27-38.
32. Huttner KM, Bevins CL Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res 1999, 45:785-794.
33. van der Poll T, Opal SM Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009, 374:1543-1556.
34. Proud D, Leigh R Epithelial cells and airway diseases. Immunol Rev 2011, 242:186-204.
35. Hearps AC, Martin GE, Angelovich TA, et al. Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell 2012, 11:867-875.
36. Seidler S, Zimmermann HW, Bartneck M, Trautwein C, Tacke F Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults. BMC Immunol 2010, 11:30.
37. Meyer KC, Rosenthal NS, Soergel P, Peterson K Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Ageing Dev 1998, 104:169-181.
38. Shivshankar P, Boyd AR, Le Saux CJ, Yeh IT, Orihuela CJ Cellular senescence increases expression of bacterial ligands in the lungs and is positively correlated with increased susceptibility to pneumococcal pneumonia. Aging Cell 2011, 10:798-806.
39. van Duin D, Mohanty S, Thomas V, et al. Age-associated defect in human TLR-1/2 function. J Immunol 2007, 178:970-975.
40. Nyugen J, Agrawal S, Gollapudi S, Gupta S Impaired functions of peripheral blood monocyte subpopulations in aged humans. J Clin Immunol 2010, 30:806-813.
41. Hinojosa E, Boyd AR, Orihuela CJ Age-associated inflammation and toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia. J Infect Dis 2009, 200:546-554.
42. Boyd AR, Shivshankar P, Jiang S, Berton MT, Orihuela CJ Age-related defects in TLR2 signaling diminish the cytokine response by alveolar macrophages during murine pneumococcal pneumonia. Exp Gerontol 2012, 47:507-518.
43. Rottinghaus EK, Vesosky B, Turner J TLR-2 independent recognition of Mycobacterium tuberculosis by CD11c+ pulmonary cells from old mice. Mech Ageing Dev 2010, 131:405-414.
44. Birjandi SZ, Ippolito JA, Ramadorai AK, Witte PL Alterations in marginal zone macrophages and marginal zone B cells in old mice. J Immunol 2011, 186:3441-3451.
45. Thompson AB, Scholer SG, Daughton DM, Potter JF, Rennard SI Altered epithelial lining fluid parameters in old normal individuals. J Gerontol 1992, 47:M171-M176.
46. Goldmann O, Lehne S, Medina E Age-related susceptibility to Streptococcus pyogenes infection in mice: underlying immune dysfunction and strategy to enhance immunity. J Pathol 2010, 220:521-529.
47. Sadeghi HM, Schnelle JF, Thoma JK, Nishanian P, Fahey JL Phenotypic and functional characteristics of circulating monocytes of elderly persons. Exp Gerontol 1999, 34:959-970.
48. Wenisch C, Patruta S, Daxbock F, Krause R, Horl W Effect of age on human neutrophil function. J Leukoc Biol 2000, 67:40-45.
49. Simell B, Vuorela A, Ekstrom N, et al. Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis. Vaccine 2011, 29:1929-1934.
50. Weinberger B, Herndler-Brandstetter D, Schwanninger A, Weiskopf D, Grubeck-Loebenstein B Biology of immune responses to vaccines in elderly persons. Clin Infect Dis 2008, 46:1078-1084.
51. Shanley DP, Aw D, Manley NR, Palmer DB An evolutionary perspective on the mechanisms of immunosenescence. Trends Immunol 2009, 30:374-381.
52. Gomez CR, Boehmer ED, Kovacs EJ The aging innate immune system. Curr Opin Immunol 2005, 17:457-462.
53. Han SH, Kim JH, Martin M, Michalek SM, Nahm MH Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2. Infect Immun 2003, 71:5541-5548.
54. Beisswenger C, Lysenko ES, Weiser JN Early bacterial colonization induces toll-like receptor-dependent transforming growth factor beta signaling in the epithelium. Infect Immun 2009, 77:2212-2220.
55. Malley R, Henneke P, Morse SC, et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA 2003, 100:1966-1971.
56. McNeela EA, Burke A, Neill DR, et al. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog 2010, 6:e1001191.
57. Albiger B, Dahlberg S, Sandgren A, et al. Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell Microbiol 2007, 9:633-644.
58. Gordon S, Taylor PR Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5:953-964.
59. Davis KM, Nakamura S, Weiser JN Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J Clin Invest 2011, 121:3666-3676.
60. Opitz B, Puschel A, Schmeck B, et al. Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem 2004, 279:36426-36432.
61. Lu YJ, Gross J, Bogaert D, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 2008, 4:e1000159.
62. Zhang Z, Clarke TB, Weiser JN Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 2009, 119:1899-1909.
63. Malley R Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development. J Mol Med (Berl) 2010, 88:135-142.
64. Mizgerd JP Acute lower respiratory tract infection. N Engl J Med 2008, 358:716-727.
65. Kohut ML, Senchina DS, Madden KS, Martin AE, Felten DL, Moynihan JA Age effects on macrophage function vary by tissue site, nature of stimulant, and exercise behavior. Exp Gerontol 2004, 39:1347-1360.
66. Higashimoto Y, Fukuchi Y, Shimada Y, et al. The effects of aging on the function of alveolar macrophages in mice. Mech Ageing Dev 1993, 69:207-217.
67. Butcher SK, Chahal H, Nayak L, et al. Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J Leukoc Biol 2001, 70:881-886.
68. Christy RM, Baskurt OK, Gass GC, Gray AB, Marshall-Gradisnik SM Erythrocyte aggregation and neutrophil function in an aging population. Gerontology 2010, 56:175-180.
69. Amaya RA, Baker CJ, Keitel WA, Edwards MS Healthy elderly people lack neutrophil-mediated functional activity to type V group B Streptococcus. J Am Geriatr Soc 2004, 52:46-50.
70. Chelvarajan RL, Liu Y, Popa D, et al. Molecular basis of age-associated cytokine dysregulation in LPS-stimulated macrophages. J Leukoc Biol 2006, 79:1314-1327.
71. Fallah MP, Chelvarajan RL, Garvy BA, Bondada S Role of phosphoinositide 3-kinase-Akt signaling pathway in the age-related cytokine dysregulation in splenic macrophages stimulated via TLR-2 or TLR-4 receptors. Mech Ageing Dev 2011, 132:274-286.
72. Cecilio CA, Costa EH, Simioni PU, Gabriel DL, Tamashiro WM Aging alters the production of iNOS, arginase and cytokines in murine macrophages. Braz J Med Biol Res 2011, 44:671-681.
73. Mahbub S, Deburghgraeve CR, Kovacs EJ Advanced age impairs macrophage polarization. J Interferon Cytokine Res 2012, 32:18-26.
74. Chelvarajan RL, Collins SM, Van Willigen JM, Bondada S The unresponsiveness of aged mice to polysaccharide antigens is a result of a defect in macrophage function. J Leukoc Biol 2005, 77:503-512.
75. Spencer NF, Poynter ME, Im SY, Daynes RA Constitutive activation of NF-kappa B in an animal model of aging. Int Immunol 1997, 9:1581-1588.
76. Jatczak B, Leszek J, Siemieniec I, et al. Age- and disease-related innate immunity of human leukocytes ex vivo. Exp Gerontol 2012, 47:8-13.
77. Gon Y, Hashimoto S, Hayashi S, Koura T, Matsumoto K, Horie T Lower serum concentrations of cytokines in elderly patients with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly. Clin Exp Immunol 1996, 106:120-126.
78. Bruunsgaard H, Skinhoj P, Qvist J, Pedersen BK Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. J Infect Dis 1999, 180:551-554.
79. Smith BL, Hostetter MK C3 as substrate for adhesion of Streptococcus pneumoniae. J Infect Dis 2000, 182:497-508.
80. Brown JS, Hussell T, Gilliland SM, et al. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci USA 2002, 99:16969-16974.
81. Bellavia D, Frada G, Di Franco P, et al. C4, BF, C3 allele distribution and complement activity in healthy aged people and centenarians. J Gerontol A Biol Sci Med Sci 1999, 54:B150-B153.
82. Koga T, McGhee JR, Kato H, Kato R, Kiyono H, Fujihashi K Evidence for early aging in the mucosal immune system. J Immunol 2000, 165:5352-5359.
83. Fujihashi K, Kiyono H Mucosal immunosenescence: new developments and vaccines to control infectious diseases. Trends Immunol 2009, 30:334-343.
84. Hagiwara Y, McGhee JR, Fujihashi K, et al. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue. J Immunol 2003, 170:1754-1762.
85. Fukuyama Y, King JD, Kataoka K, et al. A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice. J Immunol 2011, 186:2454-2461.
86. Meyer KC, Ershler W, Rosenthal NS, Lu XG, Peterson K Immune dysregulation in the aging human lung. Am J Respir Crit Care Med 1996, 153:1072-1079.
87. Schmid P, Selak S, Keller M, et al. Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age. Vaccine 2011, 29:3982-3989.
88. Simell B, Lahdenkari M, Reunanen A, Kayhty H, Vakevainen M Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins. Clin Vaccine Immunol 2008, 15:1391-1397.
89. Kolibab K, Smithson SL, Shriner AK, et al. Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity. Immun Ageing 2005, 2:10.
90. Park S, Nahm MH Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations. Infect Immun 2011, 79:314-320.
91. Schenkein JG, Park S, Nahm MH Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency. Vaccine 2008, 26:5521-5526.
92. Romero-Steiner S, Musher DM, Cetron MS, et al. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis 1999, 29:281-288.
93. Shi Y, Yamazaki T, Okubo Y, Uehara Y, Sugane K, Agematsu K Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J Immunol 2005, 175:3262-3267.
94. McCool TL, Weiser JN Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect Immun 2004, 72:5807-5813.
95. Malley R, Trzcinski K, Srivastava A, Thompson CM, Anderson PW, Lipsitch M CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci USA 2005, 102:4848-4853.
96. Trzcinski K, Thompson C, Malley R, Lipsitch M Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model. Infect Immun 2005, 73:7043-7046.
97. Moberley S, Holden J, Tatham DP, Andrews RM Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2013, 1. CD000422.
98. Makela PKH Vaccine-induced immunity to pneumococcal infection. The pneumococcus 2004, 403-420. American Society for Microbiology, Washington, DC. E.I. Tuomanen, D. Morrison, B. Spratt (Eds.).
99. Rodenburg GD, Sanders EA, van Gils EJ, et al. Salivary immune responses to the 7-valent pneumococcal conjugate vaccine in the first 2 years of life. PLoS One 2012, 7:e46916.
100. Orsini G, Legitimo A, Failli A, Massei F, Biver P, Consolini R Enumeration of human peripheral blood dendritic cells throughout the life. Int Immunol 2012, 24:347-356.
101. van Gils EJ, Veenhoven RH, Hak E, et al. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial. JAMA 2009, 302:159-167.
102. Metersky ML, Dransfield MT, Jackson LA Determining the optimal pneumococcal vaccination strategy for adults: is there a role for the pneumococcal conjugate vaccine?. Chest 2010, 138:486-490.
103. Musher DM, Sampath R, Rodriguez-Barradas MC The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence?. Clin Infect Dis 2011, 52:633-640.
104. Simonsen L, Taylor RJ, Young-Xu Y, Haber M, May L, Klugman KP Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. mBio 2011, 2:e00309-e00310.
105. Miller E, Andrews NJ, Waight PA, Slack MPE, George RC Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011, 11:760-768.
106. Inverarity DJ, Diggle MA Observations regarding historical accounts of pneumococcal diseases due to serotypes 1 and 3. J R Coll Physicians Edinb 2010, 40:354-361.
107. Stillman EG A contribution to the epidemiology of lobar pneumonia. J Exp Med 1916, 24:651-670.
108. Stillman EG Further studies on the epidemiology of lobar pneumonia. J Exp Med 1917, 26:513-535.
109. Rosenau MJ, Felton LD, Atwater RM Epidemiologic study of pneumonia and its mode of spread. Am J Hyg 1926, 6:463.
110. Christie IM Epidemiological significance of the serological types of pneumococci. Lancet 1934, 224:39-42.
111. Mackenzie GM The pneumococcus carrier. Trans Am Clin Climatol Assoc 1941, 57:88-101.
112. Smillie WG Epidemiology of lobar pneumonia: study of the prevalence of specific strains of pneumococci in the nasopharynx of immediate family contacts. JAMA 1933, 101:1281.
113. Viktorow LK, Semzowa OM, Oettinger IG Epidemiologie der krupposen Pneumonie. I. Mitteilung: Die Bedeutung der Bazillentrager in der Epidemiologie der krupposen Pneumonie. Zentralbl f Bakt I Abt Orig 1934, 131:162.
114. Hendley JO, Sande MA, Stewart PM, Gwaltney JM Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis 1975, 132:55-61.
115. Sailer J, Hall MW, Wilson RL, McCoy C A study of pneumococcus carriers. Arch Intern Med 1919, 24:600.
116. Putnam SD, Gray GC, Biedenbach DJ, Jones RN Pharyngeal colonization prevalence rates for Streptococcus pyogenes and Streptococcus pneumoniae in a respiratory chemoprophylaxis intervention study using azithromycin. Clin Microbiol Infect 2000, 6:2-8.
117. Millar EV, Watt JP, Bronsdon MA, et al. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members. Clin Infect Dis 2008, 47:989-996.
118. Abdullahi O, Nyiro J, Lewa P, Slack M, Scott JA The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults in Kilifi district, Kenya. Pediatr Infect Dis J 2008, 27:59-64.
119. Levine H, Balicer RD, Zarka S, et al. Dynamics of pneumococcal acquisition and carriage in young adults during training in confined settings in Israel. PLoS One 2012, 7:e46491.
120. Regev-Yochay G, Abullaish I, Malley R, et al. Streptococcus pneumoniae carriage in the Gaza strip. PLoS One 2012, 7:e35061.
121. Spijkerman J, van Gils EJ, Veenhoven RH, et al. Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands. Emerg Infect Dis 2011, 17:584-591.
122. Ferreira DM, Neill DR, Bangert M, et al. Controlled human infection and re-challenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am J Respir Crit Care Med 2013, 187:855-864.
123. Roca A, Bottomley C, Hill PC, et al. Effect of age and vaccination with a pneumococcal conjugate vaccine on the density of pneumococcal nasopharyngeal carriage. Clin Infect Dis 2012, 55:816-824.
124. da Gloria Carvalho M, Pimenta FC, Jackson D, et al. Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol 2010, 48:1611-1618.
125. Boersma WG, Lowenberg A, Holloway Y, Kuttschrutter H, Snijder JA, Koeter H The role of antigen detection in pneumococcal carriers: a comparison between cultures and capsular antigen detection in upper respiratory tract secretions. Scan J Infect Dis 1993, 25:51-56.
126. Levine H, Zarka S, Dagan R, et al. Transmission of Streptococcus pneumoniae in adults may occur through saliva. Epidemiol Infect 2012, 140:561-565.
127. Jansen AGSC, Sanders EAM, van der Ende A, van Loon AM, Hoes AW, Hak E Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity?. Epidemiol Infect 2008, 136:1448-1454.
128. van den Bergh MR, Biesbroek G, Rossen JW, et al. Associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteria. PLoS One 2012, 7:e47711.
129. Short KR, Reading PC, Wang N, Diavatopoulos DA, Wijburg OL Increased nasopharyngeal bacterial titers and local inflammation facilitate transmission of Streptococcus pneumoniae. mBio 2012, 3:e00255. 12.
130. Kikawada M, Iwamoto T, Takasaki M Aspiration and infection in the elderly: epidemiology, diagnosis and management. Drugs Aging 2005, 22:115-130.
131. Oh E, Weintraub N, Dhanani S Can we prevent aspiration pneumonia in the nursing home?. J Am Med Dir Assoc 2005, 6(3 suppl):S76-S80.
132. Webster LT, Hughes TP The epidemiology of pneumococcus infection: the incidence and spread of pneumococci in the nasal passages and throats of healthy persons. J Exp Med 1931, 53:535-552.